Pseudoprotodioscin
CAS: 102115-79-7
Rif. 3D-OP31761
1g | 705,00 € | ||
2g | 2.207,00 € | ||
5g | 4.017,00 € | ||
250mg | 346,00 € | ||
500mg | 454,00 € |
Informazioni sul prodotto
- (3β,25R)-26-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→4)]-β-<smallcap>D</span>-glucopyranoside
- Oligofurostanoside A
- Protodioscin, Pseudo-
- Pseudo-Protodioscin
- Pseudoprototribestin
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,25R)-26-(β-<smallcap>D</smallcap>-glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-O-[6-deoxy-α-<smallcap>L</span>-mannopyranosyl-(1→4)]-
Pseudoprotodioscin is a soybean extract that has been shown to have anti-inflammatory, anti-atherosclerotic, and anti-autoimmune effects. It is a natural product that belongs to the group of protodioscin derivatives. The cytotoxic effects of pseudoprotodioscin have been studied in 3T3-L1 preadipocytes. This molecule is also an inhibitor of DNA polymerase, which may account for its significant cytotoxic activity against tumor cells. Pseudoprotodioscin has been shown to be effective in the treatment of bowel diseases such as ulcerative colitis and Crohn's disease, as well as prostate cancer. Molecular docking analysis suggests that pseudoprotodioscin binds to the surface of DNA gyrase and prevents it from binding with the complementary strand of DNA during replication. This inhibition leads to cell death by preventing DNA synthesis and cell division.
Proprietà chimiche
Richiesta tecnica su: 3D-OP31761 Pseudoprotodioscin
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.